As a regulatory operating across the European Union, Brilitas EU supports the EUs commitment to protecting consumers and ensuring transparency in the digital marketplace through the Digital Services Act (DSA) and Digital Markets Act (DMA).
BPE
Brilitas Pharmaceuticals EU OÜ
Company · Estonia · EU Transparency Register 413055049244-08
1
position filed
in the 687 files tracked
1
legislative file
of 687 tracked
1
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 687 consultation files tracked so far (60,344 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 1244 companies & groups on this site, they rank #901 by legislative files engaged, a count of participation, not a measure of influence.
1
declared lobbying FTE
self-declared
€25K+
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2023
in the register since
Declares membership of
- European Medicines Agency
- European Food Safety Authority
- European Database on Medical Devices (EUDAMED)
- European Cosmetic Products Notification Portal (CPNP)
- European Parliament
Self-declared to the EU Transparency Register (snapshot 27 Oct 2026).
- Register category
- Companies & groups
- Head office
- Tallinn, Estonia
Self-declared to the EU Transparency Register (snapshot 27 Oct 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track Brilitas in PolicySpeak: request access →
Work at Brilitas Pharmaceuticals EU OÜ? so we know who speaks for it.
Their record over time
Brilitas Pharmaceuticals EU OÜ filed 1 position on 26 Aug 2025, across 1 of the 687 legislative files tracked here, attaching a full position paper 1 time.
What they argued
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put Brilitas Pharmaceuticals EU OÜ next to another organization. Same files, same register facts, side by side. Compare →
Is this your organization?
Everything on this page comes from Brilitas Pharmaceuticals EU OÜ’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.